NHS Logo

The diagnostic outcomes of men with a negative multi-parametric magnetic resonance imaging (mpMRI) for the diagnosis of prostate cancer, in low-risk biopsy naive men (Record no. 76588)

MARC details
000 -LEADER
fixed length control field 02802cam a2200193 4500
001 - CONTROL NUMBER
control field NMDX7809
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120401t2017 xxu||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Rhudd, A.
240 ## - UNIFORM TITLE
Uniform title <a href="Journal of Endourology">Journal of Endourology</a>
245 ## - TITLE STATEMENT
Title The diagnostic outcomes of men with a negative multi-parametric magnetic resonance imaging (mpMRI) for the diagnosis of prostate cancer, in low-risk biopsy naive men
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2017
500 ## - GENERAL NOTE
General note NMUH Staff Publications
500 ## - GENERAL NOTE
General note EMBASE
500 ## - GENERAL NOTE
General note 31
520 ## - SUMMARY, ETC.
Summary, etc. &lt;span style="font-size: 10pt;"&gt;&lt;span style="color: #4a4a4a; font-family: Lato, &amp;quot;Helvetica Neue&amp;quot;, Helvetica, Arial, sans-serif; text-decoration-color: initial;"&gt;Introduction &amp;amp; Objective: The routine use of pre-biopsy multiparametric MRI (mpMRI) for the early diagnosis of prostate cancer (CaP) is controversial. A consensus on the optimal management algorithm of a low risk man with a negative mpMRI is unclear. Current guidelines suggest prostate specific antigen (PSA), digital rectal examination (DRE) and shared decisionmaking should be used to determine if a biopsy should be done. mpMRI has the potential to be used as an additional screening tool to select some men to avoid biopsy, potentially lowering the associated harms and over diagnosis. This study evaluated the outcomes of low risk, mpMRI negative men at our institution. Materials and Methods: Between September 2015 and August 2016, 206 men with a PSA &amp;lt;10 ug/L underwent mpMRI for suspected CaP. 22 men were excluded for: previous TURP, previous MRI, prior biopsy or known CaP. 184 men were evaluated for PSA, MRI findings, Prostate Imaging Reporting and Data System (PI-RADS) score, transrectal ultrasound guided (TRUS) biopsy findings and Gleason scores. Results: 57/184 (31%) of mpMRIs done were thought to have no evidence of CaP (PI-RADS &amp;lt;3). 24/57(42%) of men with a negative MRI went on to have a TRUS biopsy. Of those biopsied, 9/24 (37.5%) were positive and 15/24 (62.5%) were negative for CaP. 6/9 (66.7%) positive biopsies were Gleason 3 + 3 (clinically insignificant CaP). 3/24 (12.5%) of men with a negative MRI had clinically significant CaP, as high as Gleason 4 + 5. Conclusions: Less than half of the men at low risk of prostate cancer (PSA &amp;lt;10 ug/L) that have a negative MRI went on to have a biopsy done. 12.5% of men with a negative mpMRI will have clinically significant CaP. These results indicate that until the performance of mpMRI is improved and definitive surveillance protocols are devised TRUS biopsy continues to play a role in men with negative mpMRIs.&lt;/span&gt;&amp;nbsp;[Conference abstract]&lt;/span&gt;
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Moghul, M.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name McDonald, J.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.liebertpub.com/doi/pdf/10.1089/end.2017.29029.abstracts">https://www.liebertpub.com/doi/pdf/10.1089/end.2017.29029.abstracts</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Staff publications for NMDX Ferriman Information and Library Service (North Middlesex) Ferriman Information and Library Service (North Middlesex) Online 07/06/2022   07/06/2022 07/06/2022 UNKNOWN